Ask AI

TROP2 ADC Decision Lab in NSCLC: What to Use Now, What to Watch Next, and How to Keep Patients Safe

Enhance your ability to interpret and apply current evidence for TROP2-directed ADCs in advanced/metastatic NSCLC to optimize patient care through a certified ACTiconsult, expert-authored ClinicalThought commentaries, a certified on-demand webcast, a podcast, and certified text-based modules with accompanying downloadable slides.

Share

Program Content

Events

  • Live Event
    TROP2 ADC Decision Lab in NSCLC: What to Use Now, What to Watch Next, and How to Keep Patients Safe
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

TROP2 ADCs in NSCLC
TROP2-Directed ADCs in NSCLC: Current Evidence, Emerging Therapies, and Future Treatment Strategies
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc. and Merck Sharp & Dohme LLC.

AstraZeneca

Daiichi Sankyo, Inc.

Merck Sharp & Dohme, LLC